3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
43
Lymphoma, Large B-Cell, Diffuse
35
Burkitt Lymphoma
33
Lymphoma
26
Lymphoma, Follicular
17
Rhabdomyosarcoma
13
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
13
Lymphoma, B-Cell
12
Neuroblastoma
10
Medulloblastoma
10
Lymphoma, Non-Hodgkin
10
Leukemia
10
Sarcoma, Ewing
9
Leukemia, Biphenotypic, Acute
9
Recurrence
8
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
8
Neoplasms
8
Lymphoma, T-Cell, Peripheral
8
Lymphoma, Mantle-Cell
7
Lymphoma, B-Cell, Marginal Zone
7
Hodgkin Disease
7
Wilms Tumor
5
Sarcoma
5
Retinoblastoma
5
Osteosarcoma
4
Lymphoproliferative Disorders
4
Lymphoma, T-Cell
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Ganglioneuroblastoma
4
Down Syndrome
4
Interventions
peginterferon alfa-2b
1
liposomal doxorubicin
1
dolutegravir
1
brincidofovir
1
belinostat
1
Zidovudine
1
Tenofovir
1
Taxes
1
Paclitaxel
1
Lomustine
1
Irinotecan
1
Introns
1
Gemcitabine
1
Doxorubicin
1
Cyclophosphamide
1
Carboplatin
1
Albumin-Bound Paclitaxel
1
3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia-Lymphoma, Adult T-Cell
×
Vincristine
×
1 year
×
Clear all
No trials found.